We are live on ! Find out more
TSHA icon

Taysha Gene Therapies
TSHA

46 hedge funds and large institutions have $363M invested in Taysha Gene Therapies in 2020 Q3 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46.3% more ownership

Funds ownership: 0% → 46.3% (+46%)

Holders
46
Holders Change
+46
Holders Change %
–
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
46
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$99M
2
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
+$47M
3
BlackRock
BlackRock
New York
+$43.3M
4
AG
Artal Group
Luxembourg
+$26.8M
5
CC
Casdin Capital
New York
+$19.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MWNA
26
Marshall Wace North America
New York
$780K +$819K +34,835 New
CCM
27
CAAS Capital Management
New York
$672K +$706K +30,000 New
PCM
28
Pinz Capital Management
New York
$612K +$642K +27,300 New
Jane Street
29
Jane Street
New York
$520K +$547K +23,234 New
GCP
30
GSA Capital Partners
United Kingdom
$448K +$470K +20,000 New
ZP
31
Zimmer Partners
New York
$448K +$470K +20,000 New
Wellington Management Group
32
Wellington Management Group
Massachusetts
$378K +$397K +16,889 New
PPA
33
Parametric Portfolio Associates
Washington
$307K +$322K +13,700 New
ECM
34
ExodusPoint Capital Management
New York
$292K +$306K +13,015 New
MS
35
Maven Securities
Jersey
$277K +$277K +11,784 New
UBS Group
36
UBS Group
Switzerland
$247K +$259K +11,000 New
Kovitz Investment Group Partners
37
Kovitz Investment Group Partners
Illinois
$224K +$235K +10,000 New
Norges Bank
38
Norges Bank
Norway
$224K +$235K +10,000 New
PVI
39
Pura Vida Investments
New York
$224K +$235K +10,000 New
Tudor Investment Corp
40
Tudor Investment Corp
Connecticut
$218K +$229K +9,725 New
PHK
41
Point72 Hong Kong
Hong Kong
$132K +$139K +5,890 New
BAM
42
Bullseye Asset Management
Colorado
$22K +$23.5K +1,000 New
Legal & General Group
43
Legal & General Group
United Kingdom
$20K +$21.2K +900 New
CAPTRUST Financial Advisors
44
CAPTRUST Financial Advisors
North Carolina
$8K +$8.7K +370 New
QT
45
Quantbot Technologies
New York
$6K +$7.06K +300 New
Millennium Management
46
Millennium Management
New York
$3.88K +$4.08M +173,257 New
1
2

TSHA Hedge Fund Activity: Q3 2020 in Review

46 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Taysha Gene Therapies (TSHA) for Q3 2020, worth a combined $363M.

Buyers outnumbered sellers: 46 funds opened new TSHA positions and 0 closed out — a net gain of 46 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $99M.

  • 46 institutional investors held Taysha Gene Therapies (TSHA) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $363M of Taysha Gene Therapies stock for Q3 2020.
  • 46 funds opened new Taysha Gene Therapies positions in Q3 2020 and 0 closed out, a net change of +46 holders.
  • The largest Taysha Gene Therapies buyer in Q3 2020 was Fidelity Investments, an estimated $99M added.

Based on aggregated 13F filings for Q3 2020.